Related Experiment Video
Updated: Aug 14, 2026
In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Assessment of myocardial viability in ischemic cardiomyopathy
1Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. j.j.bax@lumc.nl
Insights
Assessing myocardial viability is crucial for ischemic cardiomyopathy patients. Identifying viable tissue predicts improved cardiac function and prognosis after revascularization, guiding treatment decisions.
Area of Science:
- Cardiology
- Medical Imaging
- Cardiovascular Disease
Background:
- Ischemic cardiomyopathy cases are rising, necessitating effective treatment strategies.
- Current therapies include medical management, transplantation, cardiac resynchronization, and surgery.
- Myocardial viability assessment is increasingly vital for diagnosis and prognosis.
Purpose of the Study:
- To review and discuss various myocardial viability assessment techniques.
- To evaluate the predictive value of these techniques for post-revascularization outcomes.
Main Methods:
- Review of existing literature on myocardial viability assessment techniques.
- Discussion of techniques used in diagnostic and prognostic work-up for ischemic cardiomyopathy.
Main Results:
- Viable myocardium indicates potential for left ventricular (LV) function improvement post-revascularization.
- Non-viable tissue does not show functional recovery after revascularization.
- Accurate viability assessment is essential due to high surgical risks in this patient group.
Conclusions:
- Myocardial viability assessment is critical for guiding revascularization decisions in ischemic cardiomyopathy.
- Techniques for assessing viability predict improvements in LV function, exercise capacity, reverse LV remodeling, and long-term prognosis.
- Careful analysis of viability is necessary to justify the risks associated with surgical interventions.
Abstract:
The number of patients with ischemic cardiomyopathy has increased extensively over recent years. Therapies include medical treatment, cardiac transplantation, cardiac resynchronization therapy and surgery. In the diagnostic and prognostic work-up, the assessment of myocardial viability has become more important over time. In particular, patients with viable myocardium can improve in LV function after revascularization; this will not occur in patients without viable tissue. In view of the high risk of surgery in this patient category, careful analysis is needed in order to justify the enhanced risk. Over the years, different viability techniques have been developed. In this review, these techniques are discussed. Moreover, the value of these techniques for the prediction of not only improvement of function, but also improvement in exercise capacity, reverse LV remodeling, and long-term prognosis, is discussed.
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:29Cardiomyopathy V: Interprofessional Care